Scientists demonstrate a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. The research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.
Click here for original story, Possible new treatment for triple-negative breast cancer
Source: ScienceDaily